跳至主要内容
临床试验/NCT05430711
NCT05430711Unknown4 期

Induction of Labour With Dinoprostone vs. Expectant Management After Prelabour Rupture of Membranes at Term

University Medical Centre Ljubljana0 个研究点目标入组 70 人开始时间: 2022年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
70
主要终点
Time from randomisation to delivery

研究概览

简要总结

Prelabour rupture of membranes (PROM) is associated with intrauterine infection and maternal and neonatal consequences. This risk increases with the length of time from PROM to delivery. Induction of labor has been shown to reduce the rates of those complications, however the optimal time interval has not yet been determined.

The main purpose of this single-center randomized prospective study is to assess the differences between two approaches of managing PROM at term-expectant management and induction with a dinoprostone vaginal delivery system.

详细描述

Women with singleton pregnancy in cephalic presentation at term (37-41 6/7 weeks gestational age) will be randomised 4 to 12 hours after PROM when a sterile vaginal exam will be completed to assign Bishop score. When Bishop score at presentation will be ≤5, the study will be presented to the patient. Once the patient will be consented and randomized, women will receive dinoprostone vaginal delivery system (for up to 24 hours after randomisation) or will be managed expectantly (for up to 24 hours after randomisation).

Patients randomized to the expectant management group will be admitted to the maternity ward, where they will wait up to a maximum of 24 hours for labor to start spontaneously.

Patients in the induction group will also be admitted to the maternity ward and induced with a dinoprostone vaginal delivery system. If not removed sooner, the vaginal delivery system will be removed after 24h.

If patients in both groups will not be in active labor 24 hours after randomisation they will be admitted to the delivery room and health care providers will manage active labor per usual practice. The need for cesarean section or operative delivery or will be at the discretion of the healthcare provider.

In the days following birth, woman in both groups, will be asked to fill in a questionnaire about their satisfaction with the labour experience.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 4 to12 hours after prelabour rupture of membranes
  • 18-50 years of age
  • Parity 0 to 2
  • Singleton pregnancy
  • Cephalic presentation
  • Term (37-41 6/7 weeks gestational age)
  • Bishop score ≤5
  • Reassuring fetal status

排除标准

  • Uterine contractions
  • Signs of infection
  • Signs of non-reassuring fetal status
  • Meconium-stained amniotic fluid
  • Group B Streptococcus colonization
  • Fetal demise or major congenital anomaly
  • Intrauterine growth restriction (estimated fetal weight ≤ 3 percentile)
  • Contraindications for vaginal birth or use of prostaglandins for labor induction

研究组 & 干预措施

Dinoprostone

Experimental

Participants will receive dinoprostone 10 mg vaginal delivery system for up to 24 hours.

干预措施: Dinoprostone (Drug)

结局指标

主要结局

Time from randomisation to delivery

时间窗: Within 1 week

Time measured from randomisation to the delivery time

次要结局

  • Time from randomisation to spontaneous vaginal delivery(Within 1 week)
  • Time from PROM to delivery(Within 1 week)
  • Rate of chorioamnionitis(Within 1 week)
  • Cesarean delivery rate(Within 1 week)
  • Use of oxytocin(Within 1 week)
  • Lenght of antibiotic treatment(3 weeks)
  • Patients perception of labor (length, pain, overall satisfaction)(Within 3 weeks)
  • Instrumental delivery rate(Within 1 week)
  • Rate of postpartum maternal fever(Within 3 weeks)
  • Maternal Length of Stay(Within 3 weeks)
  • Hyperstimulation with nonreassuring fetal heart rate tracing(Within 1 week)
  • Use of antibiotics(Within 3 weeks)
  • Number of neonates, admitted to intensive care unit(Within 3 weeks)
  • Rate of endometritis(Within 3 weeks)
  • APGAR scores(Within 1 week)
  • Rate of early neonatal sepsis(Within 3 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Polona Peclin

Principal investigator

University Medical Centre Ljubljana

相似试验